SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-24-031620
Filing Date
2024-03-14
Accepted
2024-03-14 16:56:04
Documents
126
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K agen-20231231.htm   iXBRL 10-K 5112897
2 EX-10.9A agen-ex10_9a.htm EX-10.9A 14707
3 EX-21.1 agen-ex21_1.htm EX-21.1 4586
4 EX-23.1 agen-ex23_1.htm EX-23.1 3764
5 EX-31.1 agen-ex31_1.htm EX-31.1 14668
6 EX-31.2 agen-ex31_2.htm EX-31.2 14874
7 EX-32.1 agen-ex32_1.htm EX-32.1 10064
8 EX-97.1 agen-ex97_1.htm EX-97.1 43923
9 GRAPHIC img189631100_0.jpg GRAPHIC 293489
10 GRAPHIC img189631100_1.jpg GRAPHIC 161006
11 GRAPHIC img189631100_2.jpg GRAPHIC 133389
  Complete submission text file 0000950170-24-031620.txt   19009216

Data Files

Seq Description Document Type Size
12 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT agen-20231231.xsd EX-101.SCH 2205030
128 EXTRACTED XBRL INSTANCE DOCUMENT agen-20231231_htm.xml XML 3169327
Mailing Address 3 FORBES ROAD LEXINGTON MA 02421
Business Address 3 FORBES ROAD LEXINGTON MA 02421 781-674-4410
AGENUS INC (Filer) CIK: 0001098972 (see all company filings)

IRS No.: 061562417 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-29089 | Film No.: 24751054
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)